Caffeine as an Adjuvant Therapy for Late Preterm Infants With Respiratory Distress

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Prematurity · Respiratory Disease · Ventilator Lung; Newborn

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

King Salman Bin Abdulaziz Medical City, Madinah, Medina Region, Saudi Arabia
Contact: Study coordinator (Yasmeen T Aljhani) · med-ksamc-irb@moh.gov.sa · +966148499629
Contact: Principal Investigator (Nehad Nasef)
King Salman Bin Abdulaziz Medical City, Madinah, Saudi Arabia
Contact: Study coordinator (Yasmeen T Aljhani) · med-ksamc-irb@moh.gov.sa · +966148499629

Study leads

Nehad Nasef
Principal Investigator
Neonatology Consultant

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

The Role of Electroencephalography in Caffeine Discontinuation Timing in Premature Infants

Apnea Neonatal · Apnea of Prematurity

Abroad (travel likely)Recruiting

Bursa, Turkey (Türkiye)

Neonatal Data and Biobank to Study Factors Influencing Development in Preterm Infants Born at <32 Weeks' Gestation and/or <1500 g Birth Weight

Preterm Infant Development · Preterm Infant Health · Prematurity Complications

Abroad (travel likely)Recruiting

Cologne, Germany

Surfactant Administration by Insure or Thin Catheter

RDS of Prematurity · Surfactant Deficiency Syndrome Neonatal · Analgesia

Abroad (travel likely)Recruiting

Stockholm, Sweden

Extremely Preterm Respiratory Outcome Cohort

Infant, Premature · Respiratory Disease

Abroad (travel likely)Recruiting

Seoul, South Korea